Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Peter A. Lim"'
Autor:
Lauren Lim, Peter C. Lim
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101449- (2024)
This surgical film describes the steps of a novel minimally invasive surgical technique for the treatment of early-stage cervical cancer that prioritizes tumor containment and minimizes tumor seeding. Total Intracorporeal Robotic Radical Hysterectomy
Externí odkaz:
https://doaj.org/article/112cead9e94f419aa31b1fffca1e2514
Publikováno v:
Gynecologic Oncology Reports, Vol 54, Iss , Pp 101437- (2024)
Introduction: Minimally invasive radical hysterectomy (MIRH) has been reported to have a four-fold increase in recurrence compared to open radical hysterectomy (ORH) for the treatment of early-stage cervical cancer. The cause for the inferior outcome
Externí odkaz:
https://doaj.org/article/409b77a3ba284b05b2c1c150e399fc2b
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
Pseudomembranous conjunctivitis, caused by inflammation of the conjunctiva, is characterized by conjunctival injection, mucopurulent discharge, and formation of a thin membrane overlying the conjunctiva. This is often caused by a viral or bacterial i
Externí odkaz:
https://doaj.org/article/ed488cb698d04c0cb217030f55da42d2
Autor:
Benjamin L. Bosse, Victoria J. Palacios, Dustin W. Dutcher, Emily J. Etter, Peter C. Lim, Caroline A. Cobine, Gillian L. Moritz
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 2019 (2022)
Variations in vascular anatomy are of great concern to surgeons, as proper identification of aberrant arteries can reduce the risk of iatrogenic injury and improve patient outcomes. Several studies have highlighted the irregular branching pattern of
Externí odkaz:
https://doaj.org/article/6e88fdccece34151a12d5b21c59702b4
Autor:
Peter A Lim
Publikováno v:
The Journal of the International Society of Physical and Rehabilitation Medicine, Vol 2, Iss 5, Pp 87-92 (2019)
Externí odkaz:
https://doaj.org/article/7e721d911128453a9dbbd080907bac91
Autor:
Jiheum Paek, Peter C. Lim
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 4, p 1122 (2022)
To evaluate safety of quick discharge after robotic radical hysterectomy (RRH) in a tertiary hospital which has the enhanced recovery after surgery (ERAS) protocol. Among 94 consecutive cervical cancer patients who had undergone RRH, operative outcom
Externí odkaz:
https://doaj.org/article/a74778d44543482ea589d5b30dc7cdba
Autor:
David C. Morgenroth, Tiffany Knowlton, Susan Apkon, Cheri A. Blauwet, Anthony S. Burns, Cecilia Córdova Vallejos, Walter Frontera, Sandra L. Hearn, Prakash Jayabalan, Peter A. Lim, Alex Moroz, Danielle Perret, Danielle Powell, Matt Puderbaugh, W. Evan Rivers, Gwendolyn Sowa, Monica Verduzco-Gutierrez, Pablo A. Celnik
Publikováno v:
American Journal of Physical Medicine & Rehabilitation. 102:159-165
Autor:
Chyi-Long Lee, Kuan- Gen Huang, Joo- Hyun Nam, Peter C Lim, Felix Wong Wu Shun, Keen Whye Lee, Hiroyuki Kanao, Yoichi Aoki, Nobuhiro Takeshima, Wachyu Hadisaputra, Zhiqing Liang, Wisit Supakarapongkul, Kung-Liahng Wang
Publikováno v:
Gynecology and Minimally Invasive Therapy, Vol 8, Iss 3, Pp 91-93 (2019)
Externí odkaz:
https://doaj.org/article/475e294af03e4b22944d638021af8cf7
Autor:
Lucy Gilbert, Ana Oaknin, Ursula A. Matulonis, Gina M. Mantia-Smaldone, Peter C. Lim, Cesar M. Castro, Diane Provencher, Sanaz Memarzadeh, Michael Method, Jiuzhou Wang, Kathleen N. Moore, David M. O'Malley
Publikováno v:
Scientia
Bevacizumab; Folate receptor alpha; Platinum-resistant ovarian cancer Bevacizumab; Receptor de folato alfa; Cáncer de ovario resistente al platino Bevacizumab; Receptor de folat alfa; Càncer d'ovari resistent al platí Purpose Evaluate the antitumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9563699908903c82ae422d0b10f7eaa2
https://hdl.handle.net/11351/9113
https://hdl.handle.net/11351/9113
Publikováno v:
Open Forum Infectious Diseases. 9
Background Only 1% of patients with penicillin allergy are truly allergic but it remains the most common drug allergy reported. Studies show that direct oral challenge is a safe method to delabel low-risk patients using institutional screening strati